Direct vasoconstriction as a possible cause for amphotericin B-induced nephrotoxicity in rats
- PMID: 1710234
- PMCID: PMC296966
- DOI: 10.1172/JCI115240
Direct vasoconstriction as a possible cause for amphotericin B-induced nephrotoxicity in rats
Abstract
In anesthetized rats we tested the hypothesis that amphotericin B (AmB) reduces glomerular filtration rate (GFR) by activating the tubuloglomerular feedback (TGF) mechanism. Infusion of 1 mg/kg AmB over 50 min was followed by a reduction in kidney GFR (from 0.47 +/- 0.03 to 0.39 +/- 0.02 ml/min per 100 g body wt during the second hour after infusion; P less than 0.05) and by an increase in urine flow and urinary chloride excretion. Single-nephron GFR (SNGFR) measured in proximal (TGF interrupted) or distal tubules (TGF intact) decreased to a similar degree from 33.4 +/- 1.8 and 30.6 +/- 1.2 nl/min in the control period to 19.7 +/- 1.9 and 21.2 +/- 1.6 nl/min during the second hour after AmB infusion (P less than 0.05). Distal chloride concentrations and TGF responses to changes in loop of Henle flow rate were not significantly altered by AmB. AmB at 10(-5) M reduced the diameter of isolated perfused afferent arterioles from rabbit kidneys. In isometrically contracting rings of rabbit aorta and renal artery in vitro AmB produced endothelium-independent constriction, with half-maximal contraction (EC50) being achieved by 1.8 x 10(-6) and 2.6 x 10(-6) M in intact vessels and 1.3 x 10(-6) and 1.7 x 10(-6) M in endothelium-denuded vessels respectively. Tension development did not occur in Ca-free media or in the presence of Ca channel blockers. Pretreatment with ouabain or Bay K 8644 potentiated the effect of AmB. The vasoconstrictive effect of AmB was counteracted by aminophylline and atrial natriuretic peptide. We conclude that the AmB-induced reduction in GFR is not caused by TGF activation and that AmB has a direct vasoconstrictor effect that is probably initiated by depolarization-induced opening of Ca channels. This effect may be an important component of the nephrotoxic actions of AmB.
Similar articles
-
Functional impairment of renal afferent arteriolar voltage-gated calcium channels in rats with diabetes mellitus.J Clin Invest. 1996 Dec 1;98(11):2564-71. doi: 10.1172/JCI119075. J Clin Invest. 1996. PMID: 8958219 Free PMC article.
-
The effect of thromboxane A2 receptor antagonism on amphotericin B-induced renal vasoconstriction in the rat.Prostaglandins. 1993 Jan;45(1):47-56. doi: 10.1016/0090-6980(93)90089-p. Prostaglandins. 1993. PMID: 8424133
-
Atrial natriuretic peptide reverses afferent arteriolar vasoconstriction and potentiates efferent arteriolar vasoconstriction in the isolated perfused rat kidney.J Pharmacol Exp Ther. 1988 Aug;246(2):522-8. J Pharmacol Exp Ther. 1988. PMID: 2969977
-
Calcium entry modulation and renal hemodynamics in the hypertensive kidney.Am J Nephrol. 1987;7 Suppl 1:17-23. doi: 10.1159/000167538. Am J Nephrol. 1987. PMID: 2450458 Review.
-
Renal hemodynamic and natriuretic effects of atrial natriuretic factor.Fed Proc. 1986 Jun;45(7):2128-32. Fed Proc. 1986. PMID: 3011521 Review.
Cited by
-
Pentoxifylline modulates activation of human neutrophils by amphotericin B in vitro.Antimicrob Agents Chemother. 1992 Feb;36(2):408-16. doi: 10.1128/AAC.36.2.408. Antimicrob Agents Chemother. 1992. PMID: 1318681 Free PMC article.
-
In vitro renal toxicity and in vivo therapeutic efficacy in experimental murine cryptococcosis of amphotericin B (Fungizone) associated with Intralipid.Antimicrob Agents Chemother. 1994 Feb;38(2):177-83. doi: 10.1128/AAC.38.2.177. Antimicrob Agents Chemother. 1994. PMID: 8192439 Free PMC article.
-
Sodium chloride treatment of amphotericin B nephrotoxicity. Standard of care?West J Med. 1995 Apr;162(4):313-7. West J Med. 1995. PMID: 7747495 Free PMC article. Review.
-
Proceedings of the American Society of Pediatric Nephrology 1993 Education Symposium, Washington, D.C., 4 May, 1993.Pediatr Nephrol. 1994 Oct;8(5):632-40. Pediatr Nephrol. 1994. PMID: 7819017 No abstract available.
-
Safety, Tolerability, and Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Pediatric Patients.Antimicrob Agents Chemother. 2017 Jan 24;61(2):e01477-16. doi: 10.1128/AAC.01477-16. Print 2017 Feb. Antimicrob Agents Chemother. 2017. PMID: 27855062 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical